• Return to Headlines

Haven Diagnostics Partners with HqO to Aid CRE Leaders in the Return to Office Pandemic-Proof Your Office through Advanced Tenant Technologies

By Shiri Gupta

NEW YORK, September 7, 2020 -- Haven Diagnostics, an infectious disease risk analytics company, has announced a partnership with HqO, the tenant experience platform for commercial office buildings. Together, they aim to provide commercial-level pandemic preparedness to CRE owners and operators.

Haven Diagnostics uses agent-based modeling software to certify and validate in-place policies and procedures, factoring in four main categories of variables: tenant profile(s), location, building layout and HVAC, and 470+ medical studies. Haven's strategic partnership with HqO and its award-winning tenant experience technology will allow owners to effectively address evolving health and safety concerns surrounding their office portfolios, ensuring that tenants and employees feel safe returning to the workplace amidst growing COVID-19 concerns.

"The safety and security of tenants has always been a landlord's responsibility - and now that includes adopting a medical and health competency," Reid Snyder, HqO's Director of Platform said. "Haven helps owners and operators quantify their properties safety through its certification."

Certifications and personalized risk models developed by Haven Diagnostics have already been implemented throughout 2 million square feet across the United States. As restrictions lift and more people begin going back to work, health preparedness plans will be essential for employee health, safety, and retention. No other companies like this exist, enabling HqO's commercial partners to procure a unique approach to COVID-19 risk prevention for their tenants.

"The relationship between tenants and landlords has never been more important. HqO's platform reminds tenants that their landlord is their ally in creating a safe and productive workplace environment" Michael Gao, M.D., CEO of Haven Diagnostics, stated. Dr. Gao was previously Medical Director for Transformation and oversaw applied artificial intelligence at NewYork-Presbyterian Hospital and Assistant Professor at Weill Cornell Medicine.

About Haven Diagnostics:

Haven Diagnostics is an infectious disease risk analytics company using agent-based models to measure your property's COVID-19 risk, provide tenant and employee reassurance, monitor how it changes, and reduce it in a cost-effective way.

Haven is headquartered in New York City with offices in Dallas. To learn more about Haven and understand your property's health risk, visit www.havendiagnostics.com.

About HqO:

For owners and operators of commercial real estate, HqO is an integrated tenant experience platform and strategy solution that strengthens relationships with current and prospective tenants, unlocking business value for owners while bringing property management, marketing, and leasing teams closer to their customers. For tenants, HqO is an award-winning tenant experience mobile app - connecting employees to the communities in and around their building and empowering them with tools to control their workday. HqO is headquartered in Boston, with offices in New York City, Dallas, Los Angeles, London, and Paris. To learn more about HqO and request a software demo for your properties, visit www.hqo.co, and follow HqO on Twitter @HqOapp.

Contact:

Ben Siegel
[email protected]
212-381-6832

Keywords:

Ticker(s):